Not available in the US
When you have length of stay department metrics to meet and every minute counts, the AQT90 FLEX immunoassay analyzer can help manage bed capacity and patient flow.
Numerous studies show significant improvement in turnaround time of test results from point-of-care analyzers versus centralized placements. These differences can prove critical for care, as guidelines for cardiac markers call for a decision within a maximum of 60 minutes and ideally within 30 minutes.
National boards of technical evaluation around the world have shown that point-of-care testing improves patient flow. The savings associated with a more efficient patient flow will often offset the initial costs of moving immunoassay testing from lab to the emergency department (ED).